Tag: Motley Fool

The Medibank Private Ltd (ASX: MPL) share price is in the green today despite talk its bid for day hospital operator Cura Group, has fallen through.

Previously, it was reported the private health insurer might have been gearing up to release news of the acquisition in time for its half year results – set to drop next Friday.

At the time of writing, the Medibank share price is $3.23, 0.78% higher than its previous close.

For comparison, the S&P/ASX 200 Index (ASX: XJO) has slipped 0.8% this morning.

Let’s take a look at the latest rumours surrounding Medibank.

Medibank‘s rumoured acquisition falls through

The Medibank share price appears unfazed by rumours its acquisition of private day hospital asset Cura has failed.

The private insurer was previously reported to have agreed to buy a stake in the business for an undetermined amount.

However, The Australian today reported the deal has been abandoned prior to settling.

Cura owns day hospitals in every Australian state and in the Australian Capital Territory (ACT).

Its crown jewels include Barton Private Hospital, Sydney Day Surgery Prince Alfred, and Somerset Private Hospital.

According to the publication, while the proposed acquisition’s cost was unknown, when Fresenius Medical Care purchased its majority holding in Cura – reported to be 70% – in 2017, it valued the hospital operator at $400 million.

While the publication didn’t confirm how big of a stake in Cura that Medibank was rumoured to be purchasing, Fresenius Medical Care hit back at initial reports it was offloading any of its stake. The company said:

Fresenius Medical Care is strongly committed to long-term ownership and continues to be deeply invested in growing the Cura Day Hospitals business. There is no plan to change this approach in the foreseeable future.

Medibank share price snapshot

While it’s gaining today, this year so far has been rough on the Medibank share price.

It has fallen 5% since the start of 2022.

Though, it’s currently 14% higher than it was this time last year.

The post Medibank (ASX:MPL) share price lifts despite rumours of failed hospital bid appeared first on The Motley Fool Australia.

More reading

• Sweet dreams: ASX 200 shares that have provided big returns without the worry
• Could this give Medibank (ASX:MPL) shares a boost during earnings season?
• When might Medibank (ASX:MPL) shareholders ‘feel better’?
• How do Medibank (ASX:MPL) dividends compare to NIB?

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/a6NuXnH

The Inghams Group Ltd (ASX: ING) share price is sinking in early trade today, down 4.96%.

Inghams shares closed yesterday at $3.53 and are currently trading for $3.36.

Below we look at the highlights from Australia’s biggest integrated poultry producer’s financial results for the half-year ending 31 December (1H FY22).

Inghams share price slides on results

• Statutory earnings before interest, taxes, depreciation and amortisation (EBITDA) of $220.4 million, up 2.2% from 1H FY21; underlying EBITDA up 1.7%
• Statutory net profit after tax (NPAT) increased 8.8% year-on-year to $38.4 million; underlying NPAT was up 5.9%
• Net debt as at December 2021 of $264.6 million, with leverage of 1.3 times down from 1.7 times in December 2020
• Interim dividend of 6.5 cents per share (cps), fully franked, down from 7.5 cps in the prior corresponding period

What else happened during the half-year?

Inghams reported its group core poultry sales volume was up 5.6% from 1H FY21, powered by 6.5% growth in Australia. Its New Zealand core poultry sales volumes were flat, with the reintroduction of strict pandemic lockdowns impacting the market.

While operational efficiency programs continued, the company said COVID-19 had led to cost spikes in transport, heightened health and safety procedures, and increased overtime for its workforce, among others.

Total capital expenditure during the half-year came in at $24.0 million. Capex was down from the prior corresponding half year with some projects disrupted due to COVID and Inghams having completed its hatchery projects.

What did management say?

Commenting on the results pulling down the Inghams share price today, CEO Andrew Reeves said:

The first half of FY22 has been defined by the challenging operating environment that the business has had to navigate, which has been characterised by extended lockdowns and significant operational disruptions caused by ongoing pandemic conditions, with the most recent Omicron-related disruption to be reflected in 2H outcomes.

However, we remain optimistic about the future, especially as the impacts of Omicron recede. The first-half results are a testament to our ability to respond to external challenges and our ability to recover and adapt quickly.

What’s next?

The virus continues to cloud the short-term market outlook.

The Inghams share price could be under some pressure after management said it’s not possible to forecast how long the new variant’s impact will last. However, it said its “business is capable of recovering relatively quickly”.

The company also forecasts higher feed costs in the second half of the year. It’s holding 3-9 months of forward purchase cover on key feed ingredients.

Inghams share price snapshot

Over the past 12 months, the Inghams share price is down almost 7%. That compares to a gain of 5% posted by the S&P/ASX 200 Index (ASX: XJO).

It has also lost 7.4% year to date, compared to the benchmark’s 4.6% fall.

The post Inghams (ASX:ING) share price slumps 5% amid continued COVID impacts appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Friday
• 2 ASX dividend shares with BIG yields
• 2 ASX dividend shares that brokers say are buys
• 2 ASX shares every dividend investor needs to know about
• These were the best performing ASX 200 shares last week

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/jpXOdMW

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

After a terrible January, investors had hoped that stock markets would be able to recover in February. Yet volatility has continued to rule the day, and persistent fears about interest rates and inflation have been particularly hard on the Nasdaq Composite (NASDAQINDEX: ^IXIC). As of 2:45 p.m. ET, the Nasdaq was down almost 2.5% Thursday afternoon.

Yet some companies have been able to keep generating good financial results and keep their businesses moving in the right direction. Today, some of the best performers include Nasdaq stocks Outset Medical (NASDAQ: OM) and Global-e Online (NASDAQ: GLBE). Below, we’ll look more closely at these stocks to see why people are excited about their future prospects.

Outset looks healthy

Shares of Outset Medical moved higher by 16% on Thursday afternoon. The medical technology company reported fourth-quarter financial results that made investors excited about its future.

Outset Medical’s growth was strong. Revenue of $28.2 million rose 63% from year-ago levels, completing a full year in which sales more than doubled from 2020. Product revenue was especially favorable, posting quarterly growth of nearly 80% year over year as demand for its portable dialysis equipment remained robust.

Moreover, Outset was upbeat about its future prospects. Guidance for 2022 included revenue projections of $142 million to $150 million, which would be 38% to 46% higher than 2021’s final sales tally of $102.6 million.

Outset is still a long way from being profitable, with its fourth-quarter losses widening to $0.77 per share for the quarter. Adjusted net losses almost doubled in 2021 from 2020 levels on an absolute basis. However, investors are pleased just to see the medical equipment maker gain traction and help more patients, and that’s helping the healthcare stock regain some of the ground it had lost in the past few months.

Global-e gets a boost

Elsewhere, shares of Global-e Online rose 15%. The international e-commerce facilitator rose on favorable results from its fourth-quarter report.

Global-e’s numbers looked great. Fourth-quarter revenue climbed 54% on a 66% rise in gross merchandise value. The company posted a net loss, but that came primarily due to warrant-related expense tied to Global-e’s strategic partnership with Shopify. Global-e’s full-year 2021 results were also encouraging, with gross merchandise value soaring 87% to $1.45 billion and full-year revenue rising 80% year over year to $245 million. When you exclude the impact of the Shopify warrants, Global-e posted profits for both periods.

Global-e has gained traction quickly. Retention rates of more than 98% show that merchants tend to stick with the company once they come on board, and net dollar retention rates of 152% show that those customers expand their business over time. Global-e has been especially successful in providing its services to U.S. merchants looking for help in selling their goods and services internationally, as its U.S. outbound revenue more than doubled in 2021.

Best of all, Global-e expects another strong year in 2022. Gross merchandise value projections of $2.445 billion to $2.495 billion would represent growth of about 70% from 2021 levels. Revenue of $411 million to $421 million would be up in the same neighborhood year over year, and the company is looking for positive adjusted pre-tax operating earnings of between $38 million and $42 million for the year.

Growth stocks have to deliver the goods in today’s stock market environment. When they do, though, shareholders can still see the gains that Global-e and Outset Medical produced Thursday. 

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post As markets fall, these 2 Nasdaq stocks are surging higher appeared first on The Motley Fool Australia.

More reading

• Powering up: is the APA (ASX:APA) share price about to be electrified?
• QBE (ASX:QBE) share price sinks 9% on FY21 earnings miss
• At today’s CBA (ASX:CBA) share price, how big will the FY22 dividend yield be?
• Own A2 Milk (ASX:A2M) shares? Here’s what to expect when the company reports on Monday
• Why Bitcoin, Ethereum, and Dogecoin plunged today

Dan Caplinger owns Shopify. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and recommends Outset Medical, Inc. and Shopify. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends the following options: long January 2023 $1,140 calls on Shopify and short January 2023 $1,160 calls on Shopify. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

from The Motley Fool Australia https://ift.tt/YNxuMBL

The APA Group (ASX: APA) share price could soon get a boost by the company’s entrance into a brand-new market in New South Wales.

The S&P/ASX 50 Index (ASX: XFL) energy infrastructure business has reportedly put itself forward to help build the state’s proposed renewable energy network.

At the time of writing, the APA share price is flat today at $10.02.

Let’s take a closer look at what’s rumoured to be in store for the energy giant.

Is APA planning its break into large-scale renewable energy?

Owners of APA shares could soon hold some of NSW’s critical renewable energy infrastructure.

The company is vying to get involved in the state’s government’s plan to build renewable energy zones, according to the Australian Financial Review.

The zones will each see a single location generating renewable energy through natural assets such as wind and solar. The locations will also house energy storage systems like batteries.

As APA investors likely know, the company owns a 7,500-kilometre network of gas pipelines on Australia’s east coast and major pipelines in Western Australia and the Northern Territory.  

But the company has recently shown interest in branching into electricity infrastructure. It made an unsuccessful bid for formerly-listed $9.9 billion electricity supplier AusNet in September.

Now, according to today’s reporting, APA has put itself forward as a candidate to design, build, and control NSW’s first renewable energy zone.

Transgrid has also reportedly flagged its interest in the project.

The zone will be located in the state’s Central-West Orana region, encompassing Dubbo and Wellington.

The zone is predicted to produce 3 gigawatts of new network capacity. It’s also expected to bring up to $5.2 billion in private investment to the region by 2030. However, the news appears to have had little effect on the APA share price today.

The company’s rumoured bid comes just days after federal energy minister Angus Taylor slammed Origin Energy Ltd (ASX: ORG) for bringing forward the closure date of Australia’s largest coal-fired power station.

The Eraring power station – located in NSW’s Macquarie region – will now face its D-day in 2025.

Taylor said Origin’s decision was “bitterly disappointing” and the plant’s closure will leave a “considerable gap in reliable generation in the National Electricity Market”.

However, The Australian quoted NSW energy minister Matt Kean as responding to Taylor’s comments, saying:

He knows full well that we’ll be unlocking existing supply – it’s not a battery replacing a power station.

APA share price snapshot

It’s been a rocky start to 2022 for the APA share price. It has slipped 1.5% since the year began.

However, it is still 8.4% higher than it was this time last year.

The post Powering up: is the APA (ASX:APA) share price about to be electrified? appeared first on The Motley Fool Australia.

More reading

• Is the APA (ASX:APA) share price an attractive buy for reliability?
• 2 compelling ASX 200 shares that keep growing their dividends
• Sweet dreams: ASX 200 shares that have provided big returns without the worry
• The APA (ASX:APA) dividend has grown every year for 18 years. What’s next?
• Dividend investors should put these 2 top ASX shares on the watchlist

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns and has recommended APA Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/9Oo5QWn

The QBE Insurance Group Ltd (ASX: QBE) share price is falling on Friday following the release of its full year results.

At the time of writing, the insurance giant’s shares are down 9% to $11.51.

QBE share price sinks after earnings miss

• Gross written premiums (GWP) up 25.7% (21% in constant currency) to US$18,453 million
• GWP ex Crop up 18% year on year
• Underwriting profit up 316% year on year to US$695 million
• Combined operating ratio of 93.7%
• Statutory net profit after tax of US$750 million, compared to loss of US$1.5 billion
• Adjusted net cash profit after tax of US$805 million
• Final dividend of 19 Australian cents per share, bringing the FY 2021 dividend to 30 Australian cents per share

What happened in FY 2021?

For the 12 months ended 31 December, QBE delivered a 25.7% increase in GWP (or 21% in constant currency) to US$18,453 million. This reflects the strong premium rate environment as well as improved customer retention and new business growth across all regions. Management also notes that growth in Crop was especially strong at 51%. This was due to the significant increase in corn and soybean prices, coupled with targeted organic growth.

Positively, premium rate increases are ongoing with company-wide renewal rate increases averaging 9.7% during the year. This is consistent with the first half and 9.8% in FY 2020. And while premium rate momentum moderated slightly in International across the year, momentum accelerated in North America and Australia Pacific during the second half.

As for its profits, QBE reported a statutory FY 2021 combined operating ratio of 93.7%. This compares favourably with 104.2% in the prior year, which was significantly impacted by COVID-19 claims and adverse prior accident year claims development. Anything below 100% is profitable and vice versa if the ratio is above 100%.

This ultimately led to the company reporting a statutory net profit after tax of US$750 million, up from a loss of US$1.5 billion a year earlier. And on an adjusted net cash basis, its profit after tax came in at US$805 million.

While this looks strong on paper, it is below the market consensus estimate of US$870 million. This may explain the weakness in the QBE share price today.

Outlook

QBE’s new CEO, Andrew Horton, was pleased with the year and appears cautiously optimistic on the future.

He said: “Following another year of elevated natural catastrophe claims costs alongside rising inflationary signals and continued low interest rates, the industry operating environment remains highly uncertain. Because of this, the premium pricing environment is likely to remain positive in 2022.”

“In light of this, we expect gross written premium growth to be in the high single digits in 2022. Moreover, delivery against our strategic priorities should result in an improved and more consistent return profile over time such that the Group is capable of consistently delivering a low to mid-90’s combined operating ratio. “In FY22, we expect the business will achieve further steady improvement on the FY21 ‘exit’ combined operating ratio of ~94%.”

The post QBE (ASX:QBE) share price sinks 9% on FY21 earnings miss appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Friday
• 3 ASX shares to buy before the market rockets up again
• 2 ASX shares to buy that are perfectly set up to rally
• Own QBE (ASX:QBE) shares? Here’s what to watch when the insurer reports next week
• Is the ASX value shares party just getting started?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/CHPia9z

At today’s Commonwealth Bank of Australia (ASX: CBA) share price, is the big four ASX bank expected to offer an attractive FY22 dividend yield?

Commonwealth Bank is one of the largest banks in Australia, along with National Australia Bank Ltd (ASX: NAB), Westpac Banking Corp (ASX: WBC) and Australia and New Zealand Banking Group Ltd (ASX: ANZ). Macquarie Group Ltd (ASX: MQG) is also one of the biggest financial institutions now.

Big banks like CBA are well known for their income credentials. They have relatively low price/earnings ratio (p/e ratio) multiples. Banks usually have quite high dividend payout ratios. That combination can lead to an attractive dividend yield.

But sometimes a dividend yield can take a big hit if a company decides to reduce the dividend, like what happened during 2020 when COVID-19 struck. Bank debt provisions went up, profit went down and financial companies were told to reduce their dividend payout ratios by the financial regulator.

But those COVID effects are now unwinding and the CBA half-year profit reflected this. Expectations of higher profits can be a driver of the CBA share price.

FY22 half-year profit grows

CBA reported that for the six months to 31 December 2021, statutory net profit after tax (NPAT) went up 26% to $4.74 billion, whilst cash net profit grew 23% to $4.75 billion.

The bank explained that NPAT was supported by strong business outcomes, reduced remediation costs and lower loan loss provisions due to an improved economic outlook but impacted by lower margins.

Australia’s biggest bank revealed a high level of lending volume growth. Home lending increased by 8.5% (or $40.4 billion), whilst business lending went up by 12.5% (or $13.2 billion).

It maintained a high level of surplus capital with a common equity tier 1 (CET1) capital ratio of 11.8%. Lending volume growth offset a reduction of the net interest margin (NIM). The NIM dropped 14 basis points year on year due to lower-yielding liquid assets, increased switching to lower margin fixed home loans and continued pressure with home loan competition.

The half-year dividend was grown by 17% to $1.75 per share.

Annual dividend expectations

Analysts are expecting more dividend growth in the FY22 annual result. There are lots of different estimates out there.

The Commsec estimate, which comes from an independent third party, puts the FY22 dividend yield at 5.6% at the current CBA share price with a potential annual payment of $3.84 per share.

Citi thinks that CBA will pay a grossed-up dividend yield of 5.6%. Morgan Stanley reckons CBA will have a grossed-up dividend yield of 5.5%. Both of these brokers have a ‘sell’ rating on the bank.

One of the most pessimistic brokers on the bank, Morgans, reckons that CBA is a sell (with a price target of $77) and the FY22 grossed-up dividend yield will be just 5.1%.

CBA share price snapshot

Since the start of the year, the CBA share price has dropped 3.6%.

The post At today’s CBA (ASX:CBA) share price, how big will the FY22 dividend yield be? appeared first on The Motley Fool Australia.

More reading

• While everyone was focused on growth shares, these ASX value shares have been quietly but significantly gaining over the last 10 years
• 2 ASX 200 dividend shares that these analysts love
• Own CBA (ASX:CBA) shares? Here’s the bank’s hawkish outlook for RBA rate rises
• Why are ASX 200 bank shares getting so much love today?
• These are some of the top performing ASX 200 value shares of the past year

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Macquarie Group Limited and Westpac Banking Corporation. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/s8xoR1F

A2 Milk Company Ltd (ASX: A2M) shares will be in focus next week when the struggling infant formula company releases its half year results.

Ahead of the release, let’s take a look to see what is expected from the former market darling.

What is the market expecting from A2 Milk?

Expectations are very low for A2 Milk again in FY 2022 due to tough trading conditions and changing consumer preferences in China.

According to CommSec, the market consensus estimate is for a net profit after tax of NZ$60 million for the six months ended 31 December. This will be down 50% from NZ$120 million during the prior corresponding period.

The team at Morgans agrees with the view that A2 Milk will post a sizeable reduction in profits again.

It said: “We expect 1H22 NPAT will be down materially on the pcp given lower revenue, increased costs, five months of MVM losses, higher D&A, reduced interest income and a much higher tax rate.”

What about the full year?

Unfortunately, a similarly subdued performance is expected in the second half. For example, Bell Potter is forecasting full year net profit after tax of NZ$117.7 million on revenue of NZ$1,346.1 million. This profit is less than what it recorded during the first half of FY 2021.

However, despite its struggles, Bell Potter remains positive on A2 Milk shares. In fact, the broker has a buy rating and $7.70 price target on the company’s shares. Based on where they are trading at present, this implies potential upside of 45% over the next 12 months.

Bell Potter is positive on the future and sees potential for a big recovery in its earnings over the coming years.

It said: “We see the scope for EPS to double by FY26e, if A2M can execute on the China offline expansion strategy, while regaining 50% of the lost sales (from FY20-21) in English label IMF. Exiting the loss making US assets or navigating a turnaround at the MVM asset would likely accelerate this turnaround. We do not see the current share price as reflecting this potential.”

The post Own A2 Milk (ASX:A2M) shares? Here’s what to expect when the company reports on Monday appeared first on The Motley Fool Australia.

More reading

• The A2 Milk (ASX:A2M) share price has 40% upside – broker
• Why opening borders might not be the good news A2 Milk (ASX:A2M) shareholders have been hoping for
• The A2 Milk (ASX:A2M) share price has hit multi-year lows in 2022. Is now the time to catch the cream?
• Why has the A2 Milk (ASX:A2M) share price spilled 5% in a month?
• Can the beaten down A2 Milk (ASX:A2M) share price get back to $10?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/vW3Lb7H

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

What happened 

The value of cryptocurrencies dropped rapidly on Thursday as investors try to decipher what kind of regulation is coming to the industry in the U.S. The White House appears ready to push for regulation on the cryptocurrency industry and that uncertainty alone is spooking investors. 

As of 2 p.m. ET, Bitcoin (CRYPTO: BTC) had dropped 6.3% in the last 24 hours, Ethereum (CRYPTO: ETH) was down 6.2%, and Dogecoin (CRYPTO: DOGE) had fallen 5%. The drop has been pretty steady over the last day and doesn’t appear to be stopping at the moment. 

So what 

Current reports are that President Biden will issue an executive order next week asking for a variety of agencies to study cryptocurrencies and other digital assets. The agencies include the Departments of Treasury, State, Justice, and Homeland Security, with smaller agencies also asked to do technical reports. 

One concern is the risk to financial stability from cryptocurrencies, which have traditionally been much more volatile than currencies or even the stock market. Understanding those risks will be a part of the study. The technical aspects could also be important, which could lead to regulations intended to safeguard people’s digital assets. Given the fraud and hacking that’s taken place in cryptocurrencies over the last year, this type of regulation may be welcomed by the industry. 

We have seen big banks, small credit unions, venture capital firms, and publicly traded companies all lobby for regulation from Washington, D.C. to at least set the playing field for the industry. So an executive order like this isn’t surprising, but it’s a risk that some investors may not be willing to take right now. In any market, uncertainty is seen as a bad thing, causing selling to take place. 

It’s also worth noting that the stock market overall is down today and cryptocurrencies typically fall when the market is down. So that move could be part of the reason Bitcoin, Ethereum, and Dogecoin are down today. 

Now what 

Long term, it’s going to be a positive thing for cryptocurrencies and the crypto economy for regulation to be written. But it’s not entirely clear if the current Congress or administration is friendly to crypto or not. 

Companies and investors have been trying to get Congress and regulators to write favorable rules for years, but they’ve been fighting an uphill battle so far. Now that this is a multi-trillion dollar market it seems that political leaders are starting to take it more seriously. 

While I think that long term it’s good that crypto will get a regulatory framework, I expect there to be ups and downs in the process. Markets don’t like regulation or uncertainty, so while this expected executive order is probably a good thing for cryptocurrencies long term, the short-term reaction may still be negative. 

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Why Bitcoin, Ethereum, and Dogecoin plunged today appeared first on The Motley Fool Australia.

More reading

• How this tech giant could ‘put booster rockets’ under crypto: expert
• How this key metric bodes well for the Bitcoin price
• Why is the BetaShares Crypto Innovators ETF (ASX:CRYP) leaping 5% today?
• Ethereum and Bitcoin price in focus as world’s biggest asset manager eyes cryptos
• What did ‘Crypto Bowl’ ads do for these tokens?

Travis Hoium owns Ethereum. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and recommends Bitcoin and Ethereum. The Motley Fool Australia owns and recommends Bitcoin and Ethereum. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

from The Motley Fool Australia https://ift.tt/SuGwL8c

With demand for lithium growing strongly, analysts have consistently been revising their price forecasts higher over the last 12 months. This bodes well for the many lithium shares that are trading on the Australian share market.

But which lithium shares should you buy? Three that Bell Potter rates as buys today are listed below. Here’s what you need to know about them:

Allkem Ltd (ASX: AKE)

According to the note, Bell Potter has upgraded this lithium miner to a buy rating with a vastly improved price target of $17.00.

The broker explained: “The higher lithium price outlook has resulted in large upgrades to our AKE earnings outlook and valuation. EPS changes in this report are: FY22 +12%; FY23 +76%; and FY24 +131%. Our target price is now $17.51/sh (previously $11.00/sh). We have upgraded our recommendation to Buy.”

The broker believes Allkem is “a go-to stock for multi-project exposure to lithium markets.’

Lake Resources N.L. (ASX: LKE)

Bell Potter has retained its speculative buy rating and lifted its price target on this lithium developer’s shares to $1.82.

The broker said: “LKE’s key project is the 50ktpa lithium carbonate Kachi Lithium Brine Project in Argentina. This project is expected to employ direction lithium extraction technology which has enormous ESG benefits compared with incumbent brine and hard rock lithium production methods. With this development project, uncommitted product offtake and an independent share register, LKE has strategic appeal.”

Liontown Resources Limited (ASX: LTR)

Finally, Bell Potter has retained its speculative buy rating on this lithium developer’s shares and increased the price target on them to $3.06. Its analysts note that the company has recently signed a deal with auto giant Tesla.

Bell Potter commented: “LTR has entered a binding term sheet with Tesla for supply of up to 150ktpa spodumene concentrate from the Kathleen Valley project, adding to an agreement last month with major global battery producer LG Energy Solution (LGES). LTR now has binding term sheets in place for over half of the expected initial production from Kathleen Valley, with offtake pricing linked to market prices for lithium hydroxide. Lithium price upgrades increase our LTR valuation to $3.06/sh.”

The post Broker names 3 ASX lithium stocks to buy with huge upside potential appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX shares today
• ASX lithium shares or EV makers, what’s been the better bet?
• These 3 ASX 200 shares are topping the volume charts on Wednesday
• Why CSL, Liontown, Nearmap, and Treasury Wine shares are storming higher
• Top brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro owns Orocobre Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/uaicSxq

If you’re building an income portfolio, then you may want to look at the ASX shares listed below.

Both ASX dividend shares offer attractive yields and have been named as buys by analysts. Here’s what you need to know about them:

BHP Group Ltd (ASX: BHP)

The first ASX dividend share to consider buying is this mining giant. BHP has a collection of world class operations across a number of locations and commodities. The latter includes Petroleum, Potash, Copper, Iron ore, Coal and Nickel. Though, the company is in the process of spinning out its petroleum assets via a merger with Woodside Petroleum Limited (ASX: WPL), which shareholders will be given a slice of.

As we saw with its recent results, these commodities are commanding favourable prices at present, which is underpinning significant free cash flow generation. This is expected to continue in the near term and support generous dividend payments.

Macquarie, for example, is forecasting fully franked dividends of $4.19 per share in FY 2022 and $2.54 per share in FY 2023. Based on the current BHP share price of $47.97, this will mean yields of 8.7% and 5.3%, respectively.

Its analysts have an add rating and $54.00 price target on the company’s shares.

Centuria Industrial Reit (ASX: CIP)

Another ASX dividend share to consider is Centuria Industrial. It is a property company with a focus on high quality industrial assets that deliver income and capital growth to investors.

In FY 2022, Centuria Industrial has been experiencing strong nationwide demand for industrial space, particularly from ecommerce-related tenant customers. This resulted in Centuria Industrial reporting strong rental income growth and a 26% increase in funds from operations (FFO) to $53.9 million during the first half.

The good news for income investors is that this positive form bodes well for dividends. Morgan Stanley, for instance, is forecasting Centuria Industrial REIT to pay above guidance distributions of 18.1 cents per share this year and in FY 2023.

Based on the current Centuria Industrial REIT share price of $3.83, this will mean 4.7% dividend yields for investors. Morgan Stanley also sees decent upside. It has an overweight rating and $4.35 price target on the company’s shares.

The post 2 buy-rated ASX dividend shares with big yields appeared first on The Motley Fool Australia.

More reading

• 2 ASX dividend shares with BIG yields
• Own BHP (ASX:BHP) shares? Here’s how the ASX 200 miner is battling COVID
• Is BHP (ASX:BHP) the best ASX dividend share?
• Why BHP, Fortescue, Netwealth, and Santos shares are falling
• Top brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/vD9wryU